Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Tetra Discovery Partners Initiates Ph II Trial of Fragile X Syndrome Drug
Tetra Discovery Partners Initiates Ph II Trial of Fragile X Syndrome Drug
Tetra Discovery Partners Initiates Ph II Trial of Fragile X Syndrome Drug
Submitted by
admin
on July 10, 2018 - 11:10am
Source:
CP Wire
News Tags:
Tetra Discovery Partners
Fragile X syndrome
BPN14770
clinical trials
orphan drugs
Headline:
Tetra Discovery Partners Initiates Ph II Trial of Fragile X Syndrome Drug
snippet:
BPN14770 has received orphan drug designation
Also in trials for Alzheimer's and traumatic brain injury
Ph I trials showed excellent safety and improved cognitive capability in elderly subjects
Do Not Allow Advertisers to Use My Personal information
